Report cover image

Global Cough and Cold Medicine Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 199 Pages
SKU # APRC20557400

Description

Summary

According to APO Research, the global Cough and Cold Medicine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Cough and Cold Medicine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Cough and Cold Medicine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Cough and Cold Medicine market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Cough and Cold Medicine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Cough and Cold Medicine market include Johnson & Johnson, Novartis, Merck, Pfizer, Vertical Pharmaceuticals and Atley Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Cough and Cold Medicine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Cough and Cold Medicine, also provides the sales of main regions and countries. Of the upcoming market potential for Cough and Cold Medicine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cough and Cold Medicine sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Cough and Cold Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Cough and Cold Medicine sales, projected growth trends, production technology, application and end-user industry.

Cough and Cold Medicine Segment by Company

Johnson & Johnson
Novartis
Merck
Pfizer
Vertical Pharmaceuticals
Atley Pharmaceuticals
Cough and Cold Medicine Segment by Type

Liquid Syrup
Pill Form
Capsule
Cough and Cold Medicine Segment by Application

Adult
Children
Cough and Cold Medicine Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global Cough and Cold Medicine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Cough and Cold Medicine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Cough and Cold Medicine significant trends, drivers, influence factors in global and regions.
6. To analyze Cough and Cold Medicine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cough and Cold Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cough and Cold Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cough and Cold Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cough and Cold Medicine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cough and Cold Medicine industry.
Chapter 3: Detailed analysis of Cough and Cold Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Cough and Cold Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Cough and Cold Medicine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

199 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Cough and Cold Medicine Sales Value (2020-2031)
1.2.2 Global Cough and Cold Medicine Sales Volume (2020-2031)
1.2.3 Global Cough and Cold Medicine Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Cough and Cold Medicine Market Dynamics
2.1 Cough and Cold Medicine Industry Trends
2.2 Cough and Cold Medicine Industry Drivers
2.3 Cough and Cold Medicine Industry Opportunities and Challenges
2.4 Cough and Cold Medicine Industry Restraints
3 Cough and Cold Medicine Market by Company
3.1 Global Cough and Cold Medicine Company Revenue Ranking in 2024
3.2 Global Cough and Cold Medicine Revenue by Company (2020-2025)
3.3 Global Cough and Cold Medicine Sales Volume by Company (2020-2025)
3.4 Global Cough and Cold Medicine Average Price by Company (2020-2025)
3.5 Global Cough and Cold Medicine Company Ranking (2023-2025)
3.6 Global Cough and Cold Medicine Company Manufacturing Base and Headquarters
3.7 Global Cough and Cold Medicine Company Product Type and Application
3.8 Global Cough and Cold Medicine Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Cough and Cold Medicine Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Cough and Cold Medicine Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Cough and Cold Medicine Market by Type
4.1 Cough and Cold Medicine Type Introduction
4.1.1 Liquid Syrup
4.1.2 Pill Form
4.1.3 Capsule
4.2 Global Cough and Cold Medicine Sales Volume by Type
4.2.1 Global Cough and Cold Medicine Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Cough and Cold Medicine Sales Volume by Type (2020-2031)
4.2.3 Global Cough and Cold Medicine Sales Volume Share by Type (2020-2031)
4.3 Global Cough and Cold Medicine Sales Value by Type
4.3.1 Global Cough and Cold Medicine Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Cough and Cold Medicine Sales Value by Type (2020-2031)
4.3.3 Global Cough and Cold Medicine Sales Value Share by Type (2020-2031)
5 Cough and Cold Medicine Market by Application
5.1 Cough and Cold Medicine Application Introduction
5.1.1 Adult
5.1.2 Children
5.2 Global Cough and Cold Medicine Sales Volume by Application
5.2.1 Global Cough and Cold Medicine Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Cough and Cold Medicine Sales Volume by Application (2020-2031)
5.2.3 Global Cough and Cold Medicine Sales Volume Share by Application (2020-2031)
5.3 Global Cough and Cold Medicine Sales Value by Application
5.3.1 Global Cough and Cold Medicine Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Cough and Cold Medicine Sales Value by Application (2020-2031)
5.3.3 Global Cough and Cold Medicine Sales Value Share by Application (2020-2031)
6 Cough and Cold Medicine Regional Sales and Value Analysis
6.1 Global Cough and Cold Medicine Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Cough and Cold Medicine Sales by Region (2020-2031)
6.2.1 Global Cough and Cold Medicine Sales by Region: 2020-2025
6.2.2 Global Cough and Cold Medicine Sales by Region (2026-2031)
6.3 Global Cough and Cold Medicine Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Cough and Cold Medicine Sales Value by Region (2020-2031)
6.4.1 Global Cough and Cold Medicine Sales Value by Region: 2020-2025
6.4.2 Global Cough and Cold Medicine Sales Value by Region (2026-2031)
6.5 Global Cough and Cold Medicine Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Cough and Cold Medicine Sales Value (2020-2031)
6.6.2 North America Cough and Cold Medicine Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Cough and Cold Medicine Sales Value (2020-2031)
6.7.2 Europe Cough and Cold Medicine Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Cough and Cold Medicine Sales Value (2020-2031)
6.8.2 Asia-Pacific Cough and Cold Medicine Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Cough and Cold Medicine Sales Value (2020-2031)
6.9.2 South America Cough and Cold Medicine Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Cough and Cold Medicine Sales Value (2020-2031)
6.10.2 Middle East & Africa Cough and Cold Medicine Sales Value Share by Country, 2024 VS 2031
7 Cough and Cold Medicine Country-level Sales and Value Analysis
7.1 Global Cough and Cold Medicine Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Cough and Cold Medicine Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Cough and Cold Medicine Sales by Country (2020-2031)
7.3.1 Global Cough and Cold Medicine Sales by Country (2020-2025)
7.3.2 Global Cough and Cold Medicine Sales by Country (2026-2031)
7.4 Global Cough and Cold Medicine Sales Value by Country (2020-2031)
7.4.1 Global Cough and Cold Medicine Sales Value by Country (2020-2025)
7.4.2 Global Cough and Cold Medicine Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Cough and Cold Medicine Sales Value Growth Rate (2020-2031)
7.5.2 USA Cough and Cold Medicine Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Cough and Cold Medicine Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Cough and Cold Medicine Sales Value Growth Rate (2020-2031)
7.6.2 Canada Cough and Cold Medicine Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Cough and Cold Medicine Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Cough and Cold Medicine Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Cough and Cold Medicine Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Cough and Cold Medicine Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Cough and Cold Medicine Sales Value Growth Rate (2020-2031)
7.8.2 Germany Cough and Cold Medicine Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Cough and Cold Medicine Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Cough and Cold Medicine Sales Value Growth Rate (2020-2031)
7.9.2 France Cough and Cold Medicine Sales Value Share by Type, 2024 VS 2031
7.9.3 France Cough and Cold Medicine Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Cough and Cold Medicine Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Cough and Cold Medicine Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Cough and Cold Medicine Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Cough and Cold Medicine Sales Value Growth Rate (2020-2031)
7.11.2 Italy Cough and Cold Medicine Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Cough and Cold Medicine Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Cough and Cold Medicine Sales Value Growth Rate (2020-2031)
7.12.2 Spain Cough and Cold Medicine Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Cough and Cold Medicine Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Cough and Cold Medicine Sales Value Growth Rate (2020-2031)
7.13.2 Russia Cough and Cold Medicine Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Cough and Cold Medicine Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Cough and Cold Medicine Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Cough and Cold Medicine Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Cough and Cold Medicine Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Cough and Cold Medicine Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Cough and Cold Medicine Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Cough and Cold Medicine Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Cough and Cold Medicine Sales Value Growth Rate (2020-2031)
7.16.2 China Cough and Cold Medicine Sales Value Share by Type, 2024 VS 2031
7.16.3 China Cough and Cold Medicine Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Cough and Cold Medicine Sales Value Growth Rate (2020-2031)
7.17.2 Japan Cough and Cold Medicine Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Cough and Cold Medicine Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Cough and Cold Medicine Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Cough and Cold Medicine Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Cough and Cold Medicine Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Cough and Cold Medicine Sales Value Growth Rate (2020-2031)
7.19.2 India Cough and Cold Medicine Sales Value Share by Type, 2024 VS 2031
7.19.3 India Cough and Cold Medicine Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Cough and Cold Medicine Sales Value Growth Rate (2020-2031)
7.20.2 Australia Cough and Cold Medicine Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Cough and Cold Medicine Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Cough and Cold Medicine Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Cough and Cold Medicine Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Cough and Cold Medicine Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Cough and Cold Medicine Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Cough and Cold Medicine Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Cough and Cold Medicine Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Cough and Cold Medicine Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Cough and Cold Medicine Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Cough and Cold Medicine Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Cough and Cold Medicine Sales Value Growth Rate (2020-2031)
7.24.2 Chile Cough and Cold Medicine Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Cough and Cold Medicine Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Cough and Cold Medicine Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Cough and Cold Medicine Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Cough and Cold Medicine Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Cough and Cold Medicine Sales Value Growth Rate (2020-2031)
7.26.2 Peru Cough and Cold Medicine Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Cough and Cold Medicine Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Cough and Cold Medicine Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Cough and Cold Medicine Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Cough and Cold Medicine Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Cough and Cold Medicine Sales Value Growth Rate (2020-2031)
7.28.2 Israel Cough and Cold Medicine Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Cough and Cold Medicine Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Cough and Cold Medicine Sales Value Growth Rate (2020-2031)
7.29.2 UAE Cough and Cold Medicine Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Cough and Cold Medicine Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Cough and Cold Medicine Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Cough and Cold Medicine Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Cough and Cold Medicine Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Cough and Cold Medicine Sales Value Growth Rate (2020-2031)
7.31.2 Iran Cough and Cold Medicine Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Cough and Cold Medicine Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Cough and Cold Medicine Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Cough and Cold Medicine Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Cough and Cold Medicine Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Johnson & Johnson
8.1.1 Johnson & Johnson Comapny Information
8.1.2 Johnson & Johnson Business Overview
8.1.3 Johnson & Johnson Cough and Cold Medicine Sales, Value and Gross Margin (2020-2025)
8.1.4 Johnson & Johnson Cough and Cold Medicine Product Portfolio
8.1.5 Johnson & Johnson Recent Developments
8.2 Novartis
8.2.1 Novartis Comapny Information
8.2.2 Novartis Business Overview
8.2.3 Novartis Cough and Cold Medicine Sales, Value and Gross Margin (2020-2025)
8.2.4 Novartis Cough and Cold Medicine Product Portfolio
8.2.5 Novartis Recent Developments
8.3 Merck
8.3.1 Merck Comapny Information
8.3.2 Merck Business Overview
8.3.3 Merck Cough and Cold Medicine Sales, Value and Gross Margin (2020-2025)
8.3.4 Merck Cough and Cold Medicine Product Portfolio
8.3.5 Merck Recent Developments
8.4 Pfizer
8.4.1 Pfizer Comapny Information
8.4.2 Pfizer Business Overview
8.4.3 Pfizer Cough and Cold Medicine Sales, Value and Gross Margin (2020-2025)
8.4.4 Pfizer Cough and Cold Medicine Product Portfolio
8.4.5 Pfizer Recent Developments
8.5 Vertical Pharmaceuticals
8.5.1 Vertical Pharmaceuticals Comapny Information
8.5.2 Vertical Pharmaceuticals Business Overview
8.5.3 Vertical Pharmaceuticals Cough and Cold Medicine Sales, Value and Gross Margin (2020-2025)
8.5.4 Vertical Pharmaceuticals Cough and Cold Medicine Product Portfolio
8.5.5 Vertical Pharmaceuticals Recent Developments
8.6 Atley Pharmaceuticals
8.6.1 Atley Pharmaceuticals Comapny Information
8.6.2 Atley Pharmaceuticals Business Overview
8.6.3 Atley Pharmaceuticals Cough and Cold Medicine Sales, Value and Gross Margin (2020-2025)
8.6.4 Atley Pharmaceuticals Cough and Cold Medicine Product Portfolio
8.6.5 Atley Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Cough and Cold Medicine Value Chain Analysis
9.1.1 Cough and Cold Medicine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Cough and Cold Medicine Sales Mode & Process
9.2 Cough and Cold Medicine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Cough and Cold Medicine Distributors
9.2.3 Cough and Cold Medicine Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.